Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$8.02 - $8.67 $8,084 - $8,739
-1,008 Reduced 5.33%
17,888 $151,000
Q4 2023

Feb 06, 2024

BUY
$7.78 - $8.62 $147,010 - $162,883
18,896 New
18,896 $155,000
Q1 2023

May 04, 2023

BUY
$7.57 - $8.37 $1,998 - $2,209
264 Added 8.76%
3,277 $26,000
Q4 2022

Feb 03, 2023

BUY
$5.96 - $8.06 $16,163 - $21,858
2,712 Added 901.0%
3,013 $24,000
Q3 2022

Nov 02, 2022

BUY
$5.63 - $7.5 $1,694 - $2,257
301 New
301 $2,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.